VIRGIL THOMPSON - 27 Jun 2023 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Virgil Thompson by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
27 Jun 2023
Net transactions value
$0
Form type
4
Filing time
24 Jul 2023, 18:33:29 UTC
Previous filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +23,636 +24% 123,849 27 Jun 2023 By Thompson Family Trus F1
holding PCSA Common Stock 16,693 27 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Options Exercise $0 -23,636 -100% $0.000000* 0 27 Jun 2023 Common Stock 23,636 $0.000000 Direct F1
transaction PCSA Restricted Stock Award $0 +101,365 $0.000000 101,365 27 Jun 2023 Common Stock 101,365 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.